1776 Wealth’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

1776 Wealth’s Portfolio AYLA Stock Details AYLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-100	Closed	-$1K	–	328
2020 Q2	$1K	Buy	+100	New	+$1.39K	﹤0.01%	323

Other funds holding AYLA

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

1776 Wealth's AYLA Position: Q3 2020 in Review

1776 Wealth sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q3 2020, closing a stake of 100 shares — an estimated $1K sold.

1776 Wealth first reported a position in AYLA in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 7 funds tracked by Wall St. Rank hold AYLA as of Q3 2020.

1776 Wealth reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
1776 Wealth sold 100 Ayala Pharmaceuticals, Inc. Common Stock shares in Q3 2020, an estimated $1K.
1776 Wealth first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
1776 Wealth's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q2 2020.
7 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q3 2020.

Based on 1776 Wealth's 13F filing for Q3 2020, filed 12 Nov 2020.